Abstract
The impact of oral pathogens onto the generation and variability of oral tumors has only recently been investigated. To get further insights, oral cancer cells were treated with pathogens and additionally, as a result of this bacterial cellular infection, with human defensins, which are as anti-microbial peptide members of the innate immune system. After cell stimulation, proliferation behavior, expression analysis of oncogenic relevant defensin genes, and effects on EGFR signaling were investigated. The expression of oncogenic relevant anti-microbial peptides was analyzed with real-time PCR and immunohistochemistry. Cell culture experiments were performed to examine cellular impacts caused by stimulation, i.e., altered gene expression, proliferation rate, and EGF receptor-dependent signaling. Incubation of oral tumor cells with an oral pathogen (Porphyromonas gingivalis) and human α-defensins led to an increase in cell proliferation. In contrast, another oral bacterium used, Aggregatibacter actinomycetemcomitans, enhanced cell death. The bacteria and anti-microbial peptides exhibited diverse effects on the transcript levels of oncogenic relevant defensin genes and epidermal growth factor receptor signaling. These two oral pathogens exhibited opposite primary effects on the proliferation behavior of oral tumor cells. Nevertheless, both microbe species led to similar secondary impacts on the proliferation rate by modifying expression levels of oncogenic relevant α-defensin genes. In this respect, oral pathogens exerted multiplying effects on tumor cell proliferation. Additionally, human defensins were shown to differently influence epidermal growth factor receptor signaling, supporting the hypothesis that these anti-microbial peptides serve as ligands of EGFR, thus modifying the proliferation behavior of oral tumor cells.
Similar content being viewed by others
Abbreviations
- AKT:
-
RAC-alpha serine/threonine-protein kinase
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- ERK1/2:
-
Extracellular signal-regulated kinases 1/2
- FCS:
-
Fetal calf serum
- Gab1:
-
GRB2-associated binding protein 1
- NF-κB:
-
Nuclear factor “kappa-light-chain-enhancer” of activated B cells
- SHC:
-
SHC-transforming protein
- TLR:
-
Toll-like receptors
- Tyr:
-
Tyrosine
References
Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006;124:823–35.
Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, Sica A. Cellular and molecular pathways linking inflammation and cancer. Immunobiology. 2009;214:761–77.
Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13:759–71.
Diamond G, Beckloff N, Ryan LK. Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res. 2008;87:915–27.
Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol. 2006;42:180–218.
Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38(Suppl. 11):60–84.
Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, Taylor GW, Page RC, Beck JD, Genco RJ. Update on prevalence of periodontitis in adults in the United States: NHANES 2009-2012. J Periodontol. 2015;17:1–18.
Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8:481–90.
Güncü GN, Yilmaz DK, Könönen E, Gürsoy UK. Salivary antimicrobial peptides in early detection of periodontitis. Front Cell Infect Microbiol. 2015;5:99.
Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710–20.
Lehrer RI. Primate defensins. Nat Rev Microbiol. 2004;2:727–38.
Winter J, Kraus D, Reckenbeil J, Probstmeier R. Oncogenic relevant defensins: expression pattern and proliferation characteristics of human tumor cell lines. Tumour Biol. 2016;37(6):7959–66. doi:10.1007/s13277-015-4701-7.
Winter J, Wenghoefer M. Review: human defensins: potential tools for clinical applications. Polymers. 2012;4(1):691–709. doi:10.3390/polym4010691.
Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Investig. 2003;83:501–5.
Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 2006;66:8542–9.
Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Bergé S, Jepsen S, Winter J. Decreased gene expression of human β-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 2008;37:660–3.
Winter J, Pantelis A, Reich R, Martini M, Kraus D, Jepsen S, Allam JP, Novak N, Wenghoefer M. Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Investig. 2011;29(3):196–201.
Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol. 2007;127(3):594–604.
Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, Reich R, Martini M, Bergé S, Fischer HP, Jepsen S, Winter J. Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:351–6.
Winter J, Pantelis A, Kraus D, Reckenbeil J, Reich R, Jepsen S, Fischer HP, Allam JP, Novak N, Wenghoefer M. Human alpha-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours. BMC Cancer. 2012;12(1):465.
M.Y. Radeva, F. Jahns, A. Wilhelm, M. Glei, U. Settmacher, K.O. Greulich, et al. Defensins alpha 6 (DEFA 6) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients. BMC Cancer. 2010;10. doi:10.1186/1471-2407-10-588.
Kraus D, Deschner J, Jäger A, Wenghoefer M, Bayer S, Jepsen S, Allam JP, Novak N, Meyer R, Winter J. Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol. 2012;227(3):994–1003. doi:10.1002/jcp.22808.
Winter J, Pantelis A, Reich R, Jepsen S, Allam JP, Novak N, Wenghoefer M. Risk estimation for a malignant transformation of oral lesions by S100 A7 and doc-1 gene expression. Cancer Investig. 2011;29:478–84.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611–22.
D. Kraus, J. Reckenbeil, M. Wenghoefer, H. Stark, M. Frentzen, J.P. Allam, et al. Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression. Cell Mol Life Sci. 2016.
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76–85.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1971;227:680–5.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology. 1992;24:145–9.
Wenghoefer M, Pantelis A, Dommisch H, Götz W, Reich R, Bergé S, Martini M, Allam JP, Jepsen S, Merkelbach-Bruse S, Fischer HP, Novak N, Winter J. Nuclear hBD-1 accumulation in malignant salivary gland tumours. BMC Cancer. 2008;8:290.
Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. Down regulation and nuclear localization of human β-defensin-1 in pleomorphic adenomas of salivary glands. Oral Oncol. 2009;45:526–30.
Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol. 2009;24:353–60.
Kesting MR, Loeffelbein DJ, Hasler RJ, Wolff KD, Rittig A, Schulte M, Hirsch T, Wagenpfeil S, Jacobsen F, Steinstraesser L. Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Investig. 2009;27:575–81.
Bick RJ, Poindexter BJ, Buja LM, Lawyer CH, Milner SM, Bhat S. Nuclear lokalization of hBD-1 in human keratinocytes. J Burn Wounds. 2007;7:25–32.
Winter J, Pantelis A, Allam JP, Novak N, Reich R, Martini M, Bergé S, Deschner J, Jepsen S, Wenghoefer M. High α-defensin and S100 A7 expression and missing DOC-1 down-regulation characterize irritation fibromas of the oral cavity and may counteract malignant transformation. J Craniofac Surg. 2011;22:100–4.
Nakhjiri SF, Park Y, Yilmaz Ö, Chung WO, Watanabe K, El-Sabaeny A, Park K, Lamont RJ. Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett. 2001;200:145–9.
Shimada T, Sugano N, Nishihara R, Suzuki K, Tanaka H, Ito K. Differential effects of five Aggregatibacter actinomycetemcomitans strains on gingival epithelial cells. Oral Microbiol Immunol. 2008;23:455–8.
Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ, Yilmaz Ö. P. Gingivalis accelerated gingival epithelial cell progression through the cell cycle. Microbes Infect. 2009;10:122–8.
Kraus D, Winter J, Jepsen S, Jäger A, Meyer R, Deschner J. Interactions of adiponectin and lipopolysaccharide from Porphyromonas gingivalis on human oral epithelial cells. PLoS One. 2012;7(2):e30716.
Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, Nussbaum G, Elkin M. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015;6:22613–23.
Mas JM, Aloy P, Marti-Renom MA, Oliva B, de Llorens R, Avilés FX, Querol E. Classification of protein disulphide-bridge topologies. J Comp Aided Mol Des. 2001;15:477–87.
Benitez BAS, Komives EA. Disulfide bond plasticity in epidermal growth factor. Proteins. 2000;40:168–74.
Kim D, Dai J, Fai LY, Yao H, Son YO, Wang L, Prathesshkumar P, Kondo K, Shi X, Zhang Z. Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr (VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development. J Biol Chem. 2015;290(4):2213–24. doi:10.1074/jbc.M114.619783.
Acknowledgments
The authors are grateful to D. Lalaouni and I. Beier for their technical assistance. TH, NN, MW, SJ, and JW were supported by a grant of the German Research Foundation (KFO 208; TH (TP9/10), NN (TP1), SJ (TP2), MW, and JW (TP10)) and the Medical Faculty of the University of Bonn.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
T. Hoppe and D. Kraus contributed equally to this work.
Rights and permissions
About this article
Cite this article
Hoppe, T., Kraus, D., Novak, N. et al. Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins. Tumor Biol. 37, 13789–13798 (2016). https://doi.org/10.1007/s13277-016-5281-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-016-5281-x